Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...

The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...

The research aim is to develop an intelligent agent for cybersecurity systems capable of detecting abnormal user behavior ...

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the main causes of cancer-related mortality.

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ:REGN) PD-1 inhibitor Libtayo (cemiplimab-rwlc) as an adjuvant treatment for adult patients ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

AI is only as strong as the data beneath it. Fragmented, inconsistent or stale data will derail even the most advanced models. My previous MarTech article, “Operationalizing generative AI for ...

Abstract: This article proposes a novel data-driven distributed recurrent neural network (DDD-RNN) based on neurodynamics principles to address the challenge of precise collaborative motion generation ...

As the pre-owned electric vehicle population grows, so too does the importance of measuring EV battery health. And its potential impact on residual values. With that in mind, J.D. Power ALG is now ...

Breast surgeon, Professor Eisuke Fukuma, a highly regarded cryoablation expert & ProSense® user at Kameda Medical Center, presented updated breast cancer cryoablation data from an independent study of ...